<span id="midArticle_start"/> (Reuters) - Aerie Pharmaceuticals Inc saidits lead experimental drug failed to show that it was notinferior to a commonly prescribed eye drop in a late-stagestudy.
<span id="midArticle_0"/>The company said its experimental eye drop, RhopressaTM, didnot lower pressure inside the eye as much as timolol as measuredat the end of three different time periods. (Reporting by Vidya L Nathan in Bengaluru; Editing by SaumyadebChakrabarty)
<span id="midArticle_1"/>
<span id="midArticle_0"/>The company said its experimental eye drop, RhopressaTM, didnot lower pressure inside the eye as much as timolol as measuredat the end of three different time periods. (Reporting by Vidya L Nathan in Bengaluru; Editing by SaumyadebChakrabarty)
<span id="midArticle_1"/>
via Smart Health Shop Forum http://ift.tt/1QpRtka
No comments:
Post a Comment